Equities

Carmat SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Carmat SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.099
  • Today's Change0.00 / 0.00%
  • Shares traded806.32k
  • 1 Year change-89.35%
  • Beta1.3190
Data delayed at least 15 minutes, as of Sep 24 2025 16:35 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

  • Revenue in EUR (TTM)6.97m
  • Net income in EUR-51.40m
  • Incorporated2008
  • Employees153.00
  • Location
    Carmat SA36, avenue de l'EuropeVELIZY VILLACOUBLAY 78140FranceFRA
  • Phone+33 139456450
  • Fax+33 139456451
  • Websitehttps://www.carmatsa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aton SA-100.00bn-100.00bn4.97m9.00--11.79----------0.0005-----------17.95---27.45-------741.480.3307--0.8386--0.326821.1886.01------
Carmat SA6.97m-51.40m6.36m153.00------0.9128-1.21-1.210.1566-0.77080.1461.401.4845,549.02-107.63-80.36-152.29-100.51-338.50---737.48-2,088.981.01-15.432.46--149.16--4.59--18.44--
Spineway SA10.99m-1.90m6.50m43.00--0.2726--0.592-0.0488-0.04880.24510.67130.37390.62053.44224,244.90-6.47-25.14-7.73-30.7671.3376.66-17.29-77.572.04-0.85290.0607--13.6018.9540.63---27.97--
Bluelinea SA10.26m-753.92k9.21m79.00--8.9110.110.8974-0.0599-0.05990.81510.05611.040.474412.49115,324.50-7.61-21.89-25.35-51.8498.5494.99-7.35-23.710.3257-7.620.8821---3.888.4221.57--21.85--
Spineguard SA4.32m-2.56m12.47m15.00--2.00--2.89-0.0459-0.04590.07670.06640.49691.444.26196,474.10-29.46-27.72-45.24-47.3970.9873.78-59.29-59.200.8202-5.140.3472--7.77-7.4126.33--10.00--
Laboratoires Euromedis SA38.40m-5.48m12.91m44.00--0.7701--0.3362-1.93-1.9313.515.830.90092.764.01872,683.60-12.988.24-17.9711.7826.7732.38-14.416.092.25-16.410.3414--6.39-14.02-146.59------
Intrasense SA2.65m-6.48m13.76m76.00------5.20-0.1231-0.12310.0503-0.02210.2982--3.2734,815.79-73.01-38.28-205.39-56.1664.1385.39-244.82-85.81---116.176.65---32.04-7.51-58.01--29.78--
Biosynex SA97.95m-70.99m19.31m486.00--0.4269--0.1971-4.31-4.316.162.410.54691.2710.61201,549.40-39.527.98-73.8710.7258.8252.27-72.268.760.4506-11.460.5825--8.8124.20-16.73------
Mauna Kea Technologies SA7.48m-10.39m24.17m61.00------3.23-0.1407-0.14070.1015-0.36890.48541.194.59115,015.40-68.47-47.72---149.1943.2018.06-141.06-129.390.1177--9.54---26.960.5957-179.15---31.06--
Ikonisys SA617.19k-2.70m25.35m10.00--1.06--41.07-0.1334-0.13340.06091.510.02520.81033.4061,719.00-11.01---14.76--0.943---437.39--0.0691-30.680.1686---27.28--7.38------
Data as of Sep 24 2025. Currency figures normalised to Carmat SA's reporting currency: Euro EUR

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Friedland Gestion SASas of 25 Jul 202513.57k0.02%
Data from 31 Oct 2025 - 31 Oct 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.